Liletta is under study in a prospective phase 3 clinical trial aimed at extending the approved duration of this levonorgestrel 52-mg IUS.
Suji Uhm, MD, MPH
Advertisement
Articles by Suji Uhm, MD, MPH
Advertisement
Latest Updated Articles
Liletta IUS: not just for long-term contraceptionPublished: May 14th 2020 | Updated:
Advertisement
Advertisement